SCRI Oncology Partners 335 24th Avenue North, Nashville, TN 37203

SCRI Oncology Partners is a leading institution located in Nashville, Tennessee, specializing in oncology research and treatment. Affiliated with the renowned Sarah Cannon Research Institute (SCRI), our team of internationally recognized experts have decades of experience in conducting clinical trials and providing personalized care for patients facing various types of cancer. From breast cancer to melanoma, our dedicated team offers access to the latest treatment options and innovative therapies, all within the comfort of the local community.

Led by esteemed medical oncologists such as Dr. David R. Spigel and Dr. Erika P. Hamilton, SCRI Oncology Partners is committed to reducing inpatient hospital admissions and emergency department visits while offering state-of-the-art care and opportunities to participate in clinical trials with cutting-edge treatments. Our services include chemotherapy, immunotherapies, and next-generation sequencing, all aimed at advancing cancer care and improving patient outcomes.

To schedule an appointment or learn more about our services, please contact us at 615-329-7640 or email [email protected]. Experience the difference of expert-led care and groundbreaking research at SCRI Oncology Partners.